OPTITORQUE 40-5021Recalls & reported problems
Terumo Corporation · RADIFOCUS OPTITORQUE Angiographic Catheter · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 04987350700063), received between Dec 4, 2019 and Dec 10, 2019 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Contamination /Decontamination Problem” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Contamination /Decontamination Problem1
Patient problems
- Blood Loss2
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 10, 2019Contamination /Decontamination Problem; Contamination /Decontamination Problem
THE USER FACILITY REPORTED THAT THERE WAS A RED FOREIGN MATTER WAS OBSERVED IN THE HUB OF THE INVOLVED NEEDLE K-PACK II 30GX 1/2''-0,3X12MM-THIN WALL-SHORT CASE. THERE WAS NO HARM TO THE PATIENT. THE EVENT OCCURRED PRE-TREATMENT. ADDITIONAL INFORMATION WAS RECEIVED ON 19NOV2019. ONE CASE HAPPENED AMONG 90,000 PIECES. ADDITIONAL INFORMATION WAS RECEIVED ON 22NOV2019. THERE WAS NO DELAY, NO IMPACT ON PATIENT OR USER.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 9443400 ↗InjuryDec 4, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE USER FACILITY REPORTED THAT THE INVOLVED OPTITORQUE ANGIOGRAPHIC CATHETER DEVICE DID NOT FAIL; HOWEVER, PATIENT INJURY OCCURRED. THIS PHYSICIAN WAS PERFORMING A RADIAL LEFT HEART CATHETERIZATION. HE ALWAYS USES THE JACKY CATH FOR THE LEFT VENTRICULAR ANGIOGRAM (LV GRAM) AS WELL AS IMAGING THE CORONARY ARTERIES. WHILE INJECTING THROUGH THE CATH FOR THE LV GRAM, THE MYOCARDIUM CAME IN CONTACT WITH THE TIP OF THE CATH DURING A SYSTOLIC CONTRACTION. THE POWER OF THE INJECTION BROKE THROUGH THE MYOCARDIUM AND FILLED THE PERICARDIAL SPACE WITH CONTRAST. THE WALL OF THE LV WAS COMPROMISED AND REQUIRED IMMEDIATE ATTENTION. A PERICARDIOCENTESIS WAS PERFORMED AND THEN THE PATIENT WAS LATER TAKEN TO THE OPERATING ROOM. THE SURGEON OPENED THE ANTERIOR CHEST WALL AND PLACED A SINGLE SUTURE TO CLOSE THE COMPROMISED MYOCARDIUM. THE PATIENT DID FINE WITH THE SURGERY AND WAS THEN TRANSFERRED TO THE INTENSIVE CARE UNIT FOR RECOVERY. A POWER INJECTOR WAS USED FOR THE LV INJECTION. THE SETTING WAS AT A FLOW RATE OF 10CC PER SECOND, FOR A TOTAL OF 20CC DELIVERED. THE PSI LIMIT WAS AT 1000. AN ACCURATE ESTIMATE OF BLOOD LOSS COULD NOT BE PROVIDED. ADDITIONAL INFORMATION WAS RECEIVED ON 08NOV2019. TH
Patient problems: Blood Loss
MAUDE report 9411309 ↗InjuryDec 4, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THE USER FACILITY REPORTED THAT THE INVOLVED OPTITORQUE ANGIOGRAPHIC CATHETER DEVICE DID NOT FAIL; HOWEVER, PATIENT INJURY OCCURRED. THIS PHYSICIAN WAS PERFORMING A RADIAL LEFT HEART CATHETERIZATION. HE ALWAYS USES THE JACKY CATH FOR THE LEFT VENTRICULAR ANGIOGRAM (LV GRAM) AS WELL AS IMAGING THE CORONARY ARTERIES. WHILE INJECTING THROUGH THE CATH FOR THE LV GRAM, THE MYOCARDIUM CAME IN CONTACT WITH THE TIP OF THE CATH DURING A SYSTOLIC CONTRACTION. THE POWER OF THE INJECTION BROKE THROUGH THE MYOCARDIUM AND FILLED THE PERICARDIAL SPACE WITH CONTRAST. THE WALL OF THE LV WAS COMPROMISED AND REQUIRED IMMEDIATE ATTENTION. A PERICARDIOCENTESIS WAS PERFORMED AND THEN THE PATIENT WAS LATER TAKEN TO THE OPERATING ROOM. THE SURGEON OPENED THE ANTERIOR CHEST WALL AND PLACED A SINGLE SUTURE TO CLOSE THE COMPROMISED MYOCARDIUM. THE PATIENT DID FINE WITH THE SURGERY AND WAS THEN TRANSFERRED TO THE INTENSIVE CARE UNIT FOR RECOVERY. A POWER INJECTOR WAS USED FOR THE LV INJECTION. THE SETTING WAS AT A FLOW RATE OF 10CC PER SECOND, FOR A TOTAL OF 20CC DELIVERED. THE PSI LIMIT WAS AT 1000. AN ACCURATE ESTIMATE OF BLOOD LOSS COULD NOT BE PROVIDED. ADDITIONAL INFORMATION WAS RECEIVED ON 08NOV2019. TH
Patient problems: Blood Loss
MAUDE report 9411307 ↗
Other CATHETER, INTRAVASCULAR, DIAGNOSTIC devices
- TrapEase Permanent Vena Cava Filter with the VisEase Angiographic Vessel Dilator 466P306AUCordis Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC6 deaths186 reports
- Dragonfly™ OPTIS™ C408646Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC4 deaths150 reports
- Dragonfly OpStar™ 1014651Lightlab Imaging, Inc. · CATHETER, INTRAVASCULAR, DIAGNOSTIC1 recall87 reports
- LANGSTON IPN913559Teleflex Incorporated · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls14 reports
- Trevo 90238Stryker Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls5 reports
- Expo™ H749085263011Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls3 reports
- Expo™ H74908526501Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls1 report
- Expo™ H74908526031Boston Scientific Corporation · CATHETER, INTRAVASCULAR, DIAGNOSTIC2 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page